Used in pharmaceutical research as a key intermediate in the synthesis of kinase inhibitors, particularly those targeting tyrosine kinases involved in cancer cell proliferation. Shows potential in the development of antitumor agents due to its ability to modulate signaling pathways in malignant cells. Also employed in structure-activity relationship (SAR) studies to optimize drug candidates for improved potency and selectivity. Its heterocyclic framework enhances binding affinity to ATP-binding sites in kinases, making it valuable in designing targeted therapies for oncology.